Sec. 162.018.  BROCHURE ON UMBILICAL CORD BLOOD OPTIONS.  (a)  The executive commissioner shall prepare and update as necessary a brochure based on nationally accepted, peer reviewed, scientific research information regarding stem cells contained in the umbilical cord blood after delivery of an infant.  The information in the brochure must include:
(1)  the current and potential uses, risks, and benefits of stem cells contained in umbilical cord blood to a potential recipient of donated stem cells, including a biological family member, extended family member, or nonrelated individual;
(2)  the options available for future use or storage of umbilical cord blood after delivery of an infant, including:
(A)  discarding the stem cells;
(B)  donating the stem cells to a public umbilical cord blood bank;
(C)  storing the stem cells in a private family umbilical cord blood bank for use by immediate and extended family members; and
(D)  storing the stem cells for immediate and extended family use through a family or sibling donor banking program that provides free collection, processing, and storage when a medical need exists;
(3)  the medical process used to collect umbilical cord blood after delivery of an infant;
(4)  any risk associated with umbilical cord blood collection to the mother and the infant;
(5)  any costs that may be incurred by a pregnant woman who chooses to donate or store umbilical cord blood after delivery of the woman's infant; and
(6)  the average cost of public and private umbilical cord blood banking.
(b)  The department shall make the brochure available on the department's website and shall distribute the brochure on request to physicians or other persons permitted by law to attend a pregnant woman during gestation or at delivery of an infant.
Added by Acts 2007, 80th Leg., R.S., Ch. 104 (H.B. 709), Sec. 1, eff. May 17, 2007.
Amended by: 
Acts 2015, 84th Leg., R.S., Ch. 1 (S.B. 219), Sec. 3.0492, eff. April 2, 2015.